| 000 | 01569 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517022025.0 | ||
| 264 | 0 | _c20160404 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1440-1746 | ||
| 024 | 7 |
_a10.1111/jgh.12952 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, Fan | |
| 245 | 0 | 0 |
_aAutoimmune hepatitis: East meets west. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology and hepatology _cAug 2015 |
||
| 300 |
_a1230-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAmericas _xepidemiology |
| 650 | 0 | 4 |
_aAsia _xepidemiology |
| 650 | 0 | 4 | _aCarcinoma, Hepatocellular |
| 650 | 0 | 4 |
_aEurope _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aHLA-DR3 Antigen _xgenetics |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 |
_aHepatitis, Autoimmune _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aInfliximab _xtherapeutic use |
| 650 | 0 | 4 | _aLiver Cirrhosis |
| 650 | 0 | 4 | _aLiver Neoplasms |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aWang, Qixia | |
| 700 | 1 | _aBian, Zhaolian | |
| 700 | 1 | _aRen, Lin-Lin | |
| 700 | 1 | _aJia, Jidong | |
| 700 | 1 | _aMa, Xiong | |
| 773 | 0 |
_tJournal of gastroenterology and hepatology _gvol. 30 _gno. 8 _gp. 1230-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jgh.12952 _zAvailable from publisher's website |
| 999 |
_c24702666 _d24702666 |
||